SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* LaBauve Donald J. Jr. (Last) (First) (Middle) ALBEMARLE CORPORATION 4250 CONGRESS STREET, SUITE 900 (Street) CHARLOTTE NC 28209 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 11/11/2024	3. Issuer Name and Ticker or Trading Symbol ALBEMARLE CORP [ ALB ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) VP, Controllers and Tax, & CAO	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	5,164	D(1)
Common Stock	12,466.435	I	Albemarle Savings Plan(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	02/22/2027	02/21/2034	Common Stock	1,332	$118.18	D

Explanation of Responses:

1. The Reporting Person's direct holdings reported in Table 1, Column 2 include: 319 Restricted Stock Units ("RSUs") granted on February 26, 2021, which will vest on February 26, 2025; 521 RSUs granted on February 25, 2022, which will vest on February 25, 2025; 486 RSUs granted on February 24, 2023, which will vest on February 24, 2026; and 549 RSUs granted on February 22, 2024, which will vest on February 22, 2027. The Reporting Person's direct holdings reported in Table 1, Column 2 also include 160 Adjusted ROIC Performance Stock Units ("PSUs") granted on 02/26/2021. Payout based on 200% performance multiplier and vest on 01/01/2025. Vesting of all RSUs, PSUs and Stock Options reported in this Form 3 are subject to the terms of the applicable award agreement.

2. Total number of shares of Common Stock held in the name of the Reporting Person under the Albemarle Corporation Retirement Savings Plan (the "Albemarle Savings Plan") as of the date of this Form 3.

Remarks:

Exhibit List: Exhibit 24 Power of Attorney

	/s/ Stefanie M. Holland, Attorney-in-Fact	11/19/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.